Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease, and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nolpaza, a proton pump inhibitor, is employed in the management of acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): reduces acid exposure to relieve symptoms and promote esophageal healing. - Erosive esophagitis: facilitates mucosal repair by decreasing gastric acidity. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Adverse reactions may occur with any medication. The following list reflects reported events.

Common Side Effects: - Headache: mild to moderate head pain. - Diarrhoea: loose, watery stools. - Nausea: feeling of sickness. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Low magnesium levels: muscle cramps, irregular heartbeat. - Clostridioides difficile infection: severe diarrhoea and colitis.

Before prescribing Nolpaza, consider the following safety measures.

- Pregnancy: category B; use only if clearly needed. - Breastfeeding: weigh potential benefits against risks. - Renal impairment: monitor renal function and adjust therapy if required. - Elderly patients: may require closer observation for side effects. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in the original container, protect from moisture and light.

Nolpaza may affect the pharmacokinetics of other medicines. Review the following interactions.

Major Interactions (Avoid): - Ketoconazole: reduced absorption of ketoconazole. - Atazanavir: decreased efficacy of atazanavir. - Clopidogrel: reduced activation of clopidogrel.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR; monitor coagulation parameters. - Digoxin: possible increase in serum digoxin levels; observe for toxicity.